Waleed H. Hassanein - 22 Feb 2022 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
President & CEO, Director
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
22 Feb 2022
Transactions value $
$0
Form type
4
Filing time
24 Feb 2022, 16:45:55 UTC
Previous filing
07 Jan 2022
Next filing
09 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +250K $0.00 250K 22 Feb 2022 Common Stock 250K $13.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.